ICD-10 Coding for Ductal Carcinoma In Situ(D05.0, D05.0U, D05.1)
Learn about the ICD-10 coding and documentation requirements for ductal carcinoma in situ, including key codes, documentation tips, and common pitfalls.
Complete code families applicable to Ductal Carcinoma In Situ
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D05.1 | Intraductal carcinoma in situ of breast | Use when DCIS is confirmed via biopsy and documented with laterality. |
|
| D05.8 | Other specified carcinoma in situ of breast | Use for rare subtypes of DCIS not covered by D05.1. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutDuctal Carcinoma In Situ
Alternative codes to consider when ruling out similar conditions
Use for lobular carcinoma, not ductal.
Documentation & Coding Risks
Avoid these common issues when documenting Ductal Carcinoma In Situ.
Omitting nuclear grade in documentation
Impact
Clinical: Impacts treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims.
Mitigation
Include nuclear grade in all pathology reports.
Incorrect laterality coding
Impact
Reimbursement: May lead to incorrect billing and reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient records.
Mitigation
Verify laterality in the medical record before coding.
Incorrect use of unspecified codes
Impact
Using unspecified codes when specific information is available.
Mitigation
Ensure all documentation is reviewed for specificity before coding.